Any long-term commercial relationship, especially between a drug innovator and its CMO, requires a number of things to remain sound: ongoing dialogue, common expectations, milestones and metrics, responsiveness, secure data access and more. With time, these relational and transactional exchanges build a collaborative bridge that pushes risk out and business success into these highly technical and complex relationships.
In drug product manufacturing, quality is everything. Inconsistent quality can result in manufacturing delays, additional costs and a shortage of available products. Preventing and swiftly resolving any issues will benefit many stakeholders — including the client, the manufacturer and, ultimately, the end user of these products.